
How High Can SharkNinja Stock Go?
If you know popular consumer appliance brands Shark and Ninja,…
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
Income Statement | ||||||
Revenue | $1.5B | $2.2B | $2.4B | $639.7M | $483.6M | |
Gross Profit | $356.5M | $447.4M | $365.7M | $104.1M | $102.5M | |
Operating Income | -$24.9M | -$23.8M | -$9.6M | -$4.5M | $4K | |
EBITDA | -$38.5M | $40M | $32.6M | $18.8M | -$28.7M | |
Diluted EPS | -$0.38 | -$1.25 | -$1.23 | -$0.22 | -$0.63 |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Balance Sheet | ||||||
Current Assets | $508.3M | $463.4M | $476M | $669.2M | $727.9M | |
Total Assets | $1.3B | $1.3B | $2.6B | $2.6B | $2.7B | |
Current Liabilities | $414.5M | $382.5M | $457.6M | $659M | $739.1M | |
Total Liabilities | $688.3M | $727.9M | $1.3B | $1.6B | $1.7B | |
Total Equity | $617.3M | $611.2M | $1.3B | $1B | $935.5M | |
Total Debt | $228.7M | $282.6M | $632.3M | $597.9M | $819.3M |
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
Cash Flow Statement | ||||||
Cash Flow Operations | $37.9M | $155.5M | $18.4M | $4.9M | $4.6M | |
Cash From Investing | -$670.9M | -$30.3M | -$66.3M | -$9.7M | -$13.1M | |
Cash From Financing | $562.6M | -$83.5M | $92.4M | $14.9M | $107.9M | |
Free Cash Flow | -$993K | $130.4M | -$9.7M | -$438K | -$4M |
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
In the current month, EVH has received 9 Buy ratings 1 Hold ratings, and 0 Sell ratings. The EVH average analyst price target in the past 3 months is $15.08.
According to analysts, the consensus estimate is that Evolent Health share price will rise to $15.08 per share over the next 12 months.
Analysts are divided on their view about Evolent Health share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Evolent Health is a Sell and believe this share price will drop from its current level to $9.00.
The price target for Evolent Health over the next 1-year time period is forecast to be $15.08 according to 10 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
According to Wall Street analysts, the consensus rating for Evolent Health is a Buy. 9 of 10 analysts rate the stock a Buy at this time.
You can purchase shares of Evolent Health via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Evolent Health shares.
Evolent Health was last trading at $11.38 per share. This represents the most recent stock quote for Evolent Health. Yesterday, Evolent Health closed at $11.36 per share.
In order to purchase Evolent Health stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
If you know popular consumer appliance brands Shark and Ninja,…
Oklo (NYSE: OKLO) is only a year removed from its SPAC‑enabled debut,…
If you stopped tracking Grab Holdings (NASDAQ: GRAB) after its 2021 SPAC…
Market Cap: $4T
P/E Ratio: 56x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 34x
Veritex Holdings [VBTX] is down 3.26% over the past day.
Monopar Therapeutics [MNPR] is down 8.6% over the past day.
Nebius Group NV [NBIS] is up 2.98% over the past day.